2346-Tetrakis-O-Trimethylsilyl-D-Gluconolactone Market In Global
2,3,4,6-Tetrakis-O-Trimethylsilyl-D-Gluconolactone (CAS 32384-65-9) is a synthetic building block ... Read More
Gandotinib is identified as being highly selective for JAK2-V617F and has advanced into human clinical trials for the treatment of several myeloproliferative disorders.
This report contains market size and forecasts of Gandotinib in global, including the following market information:
Global Gandotinib Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Gandotinib Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Gandotinib companies in 2021 (%)
The global Gandotinib market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gandotinib include BioVision, Selleck Chemicals, BOC Sciences, TargetMol, MyBiosource, Adooq Bioscience, Toronto Research Chemicals, AbMole and Taiclone, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gandotinib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gandotinib Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Gandotinib Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Gandotinib Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Gandotinib Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Gandotinib Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Gandotinib Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gandotinib revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Gandotinib revenues share in global market, 2021 (%)
Key companies Gandotinib sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Gandotinib sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
BioVision
Selleck Chemicals
BOC Sciences
TargetMol
MyBiosource
Adooq Bioscience
Toronto Research Chemicals
AbMole
Taiclone
Axon Medchem
CSNpharm
AA BLOCKS
MedKoo
Wuhan Sun-Shine Bio-Technology
Biosynth Carbosynth
Biorbyt
2,3,4,6-Tetrakis-O-Trimethylsilyl-D-Gluconolactone (CAS 32384-65-9) is a synthetic building block ... Read More
Pacritinib is an orally bioavailable inhibitor of Janus kinase 2 (JAK2) and the JAK2 mutant JAK2V ... Read More
Upadacitinib is a selective JAK inhibitor under the development of AbbVie.ABT-494 is nearly 74 fo ... Read More
Momelotinib, an aminopyrimidine derivative discovered by high-throughput enzyme and cell-based sc ... Read More